Terms ending in 2040
Every in-force patent on Gilead Sciences, Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,702,414 | Thiadiazole IRAK4 Inhibitors In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | |
| US 11,174,256 | Imidazopyridine Derivatives In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 11,897,878 | Substituted 6-Azabenzimidazole Compounds In force · Medium confidence | Gilead Sciences, Inc. | In force | Medium confidence | |
| US 11,071,730 | Substituted 6-Azabenzimidazole Compounds In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 11,203,591 | Substituted 6-Azabenzimidazole Compounds In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 12,102,625 | Solid Forms of FXR Agonists In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 12,152,037 | CRYSTALLINE SUCCINATE SALT OF 6-(6-Aminopyrazin-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZO[1,2-a]PYRAZIN-8-Amine AS A SYK INHIBITOR In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US D1,063,638 | Blister Pack In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 11,339,168 | CRYSTALLINE FORMS OF 6-(6-Aminopyrazin-2-YL)-N-(4-(4-(OXETAN-3-YL)PIPERAZIN-1-YL)PHENYL)IMIDAZO[1,2-a]PYRAZIN-8-Amine AS SYK INHIBITORS In force · High confidence | Kronos Bio, Inc. | In force | High confidence | |
| US D1,064,842 | Blister Pack In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| 40 more term ends in 2040 · Pro | |||||
10 of 50 patents shown. Soonest term end first, then patent number.
Pro members see all 50.
46 of these are in force and held by Gilead Sciences, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.